期刊文献+

息风通络化瘀汤对高血压病超敏C反应蛋白及血压的影响 被引量:3

Effect of Xifengtongluohuayu Decoction on the Blood Pressure and the High sensitive C-reactive Protein of Hypertension
下载PDF
导出
摘要 目的观察息风通络化瘀汤治疗高血压病患者的临床疗效及其对超敏C反应蛋白(hs-CRP)水平的影响。方法将66例高血压病Ⅱ~Ⅲ级(肝阳上亢兼血瘀证)患者随机分为治疗组与对照组,两组均服依那普利联合氨氯地平,治疗组加服息风通络化瘀汤。比较两组血压下降情况及hs-CRP水平变化。结果两组治疗后降压效果及hs-CRP的降低程度均较明显,而以治疗组改善程度更佳。结论息风通络化瘀汤治疗高血压(肝阳上亢兼血瘀证)疗效确切,并能更好地降低hs-CRP水平。 Objective:To observe the effect of Xifengtongluohuayu Decoction on the blood pressure and the high sensitive C-reactive protein(hs-CRP) of hypertension. Methods:66 patients with liver-yang hyperactivity plus blood stasis syndrome of Ⅱ-Ⅲ grade hypertension were divided randomly into the treatment group used and control group. The control group use enalapril combined amlodipine and the control group used Xifengtongluohuayu Decoction besides previous therapy. Variations of the blood pressure and the hs-CRP level were compared between two groups. Results:After treatment,the decreases of the blood pressure and the hs-CRP level were obvious in two groups. Furthermore,the improvement of the treatment was more significant than that of the control group. Conclusion:It is obvious curative effect of the Xifengtongluohuayu Decoction on liver-yang hyperactivity plus blood stasis syndrome of hypertension. The level of the hs-CRP is reduced remarkably by it.
出处 《中国中医急症》 2010年第7期1099-1100,共2页 Journal of Emergency in Traditional Chinese Medicine
关键词 高血压病 肝阳上亢 血瘀 超敏C反应蛋白 息风通络化瘀汤 Hypertension Liver-yang hyperactivity Blood stasis syndrome hs-CRP Xifengtongluohuayu De-coction
  • 相关文献

参考文献7

二级参考文献13

  • 1聂海,祝之明,闫振成,倪银星,赵志钢,张刚,杨华.高敏C反应蛋白与代谢综合征组分及靶器官损害的关系[J].中华心血管病杂志,2004,32(12):1113-1117. 被引量:62
  • 2王阶 陈可冀 等.血瘀证诊断标准的研究[J].中西医结合杂志,1988,8(10):585-585.
  • 3Hak AE, Pols HA, Stehouwer CD, et al. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab, 2001, 86:4398-4405.
  • 4Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem,2001,47:418-425.
  • 5Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 2001,103:1813-1818.
  • 6Chae CU, Lee RT, Rifai N, et al. Blood pressure and inflammation in apparently healthy men. Hypertension, 2001,38: 399-403.
  • 7Dorffel Y, L atsch C, Stuhlmuller B, et al. Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension, 1999,34:113-117.
  • 8Winkler G, Lakatos P, Salamon F, et al. Elevated serum TNFalpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients. Diabet Med, 1999,16:207-211.
  • 9Temelkova-Kurktschiev T, Siegert G, Bergmann S, et al. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism. 2002,51:743-749.
  • 10Clearfield MB.C-reactive protein:a new risk assessment tool for cardiovascular disease.J Am Osteopath Assoc 2005; 105 (9):409-416.

共引文献762

同被引文献41

引证文献3

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部